Article citationsMore>>

Hsia, E., Seggelke, S., Gibbs, J., Hawkins, R.M., Cohlmia, E., Rasouli, N., Wang, C., Kam, I. and Draznin, B. (2012) Subcutaneous Administration of Glargine to Diabetic Patients Receiving Insulin Infusion Prevents Rebound Hyperglycemia. The Journal of Clinical Endocrinology & Metabolism, 97, 3132-3137.
https://doi.org/10.1210/jc.2012-1244

has been cited by the following article:

• TITLE: Evaluation of Insulin Infusion Rates for the Treatment of Diabetic Ketoacidosis in the Emergency Department

  AUTHORS: Megan E. Bass, Nicole Paavola, Tyree H. Kiser, Garth Wright, Gabrielle Jacknin

  KEYWORDS: Diabetic Ketoacidosis, Regular Insulin, Intravenous Insulin, Dose, Infusion Rates

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.10 No.3, March 17, 2022

  ABSTRACT: Introduction: There is minimal literature to support the appropriate dosing for the initiation of IV regular insulin therapy in DKA patients. A 0.1 unit/kg bolus followed by 0.1 units/kg/hour or 0.14 units/kg/hour is commonly utilized and recommended in guidelines. Objective: We sought to assess clinical and safety outcomes associated with various insulin infusion starting doses in patients diagnosed with DKA in the emergency department in an effort to help guide prescribing. Methods: A retrospective cohort study was conducted within an academic emergency department and included patients who received continuous infusion regular insulin with an ICD-10 code for DKA between January 2016 and January 2019. A predictive regression model was applied to test if predefined lab values influenced the starting insulin infusion rates. Clinical and safety outcomes were evaluated by starting insulin infusion rate. Data was analyzed based on starting insulin infusion rates. Results: 347 patients met inclusion criteria with 92 (26.5%) patients receiving Conclusion: Glucose levels significantly influenced the insulin starting infusion rate, with no identified differences in adverse effects or clinical outcomes.